Jennison Associates
AMED

Jennison Associates’s Amedisys AMED Stock Holding History

Jennison Associates’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,667
Closed -$4.64M – 630
2021
Q4 		$4.64M Buy
+28,667
New +$4.61M ﹤0.01% 474
2020
Q4 		– Sell
-6,233
Closed -$1.47M – 641
2020
Q3 		$1.47M Buy
+6,233
New +$1.42M ﹤0.01% 519
2020
Q2 		– Sell
-7,316
Closed -$1.34M – 627
2020
Q1 		$1.34M Buy
7,316
+174
+2% +$31K ﹤0.01% 466
2019
Q4 		$1.19M Sell
7,142
-2,029
-22% -$302K ﹤0.01% 511
2019
Q3 		$1.2M Sell
9,171
-136
-1% -$17.7K ﹤0.01% 527
2019
Q2 		$1.13M Buy
9,307
+673
+8% +$79.9K ﹤0.01% 542
2019
Q1 		$1.06M Buy
8,634
+2,226
+35% +$279K ﹤0.01% 533
2018
Q4 		$750K Buy
6,408
+126
+2% +$14.9K ﹤0.01% 559
2018
Q3 		$785K Sell
6,282
-73
-1% -$8.06K ﹤0.01% 573
2018
Q2 		$543K Sell
6,355
-2,539
-29% -$186K ﹤0.01% 619
2018
Q1 		$537K Sell
8,894
-35
-0.4% -$1.99K ﹤0.01% 608
2017
Q4 		$471K Buy
8,929
+10
+0.1% +$527 ﹤0.01% 629
2017
Q3 		$499K Buy
8,919
+29
+0.3% +$1.53K ﹤0.01% 620
2017
Q2 		$558K Sell
8,890
-13,350
-60% -$777K ﹤0.01% 606
2017
Q1 		$1.14M Sell
22,240
-9,985
-31% -$476K ﹤0.01% 569
2016
Q4 		$1.37M Sell
32,225
-3,121
-9% -$133K ﹤0.01% 578
2016
Q3 		$1.68M Sell
35,346
-50
-0.1% -$2.5K ﹤0.01% 565
2016
Q2 		$1.79M Buy
35,396
+23,681
+202% +$1.2M ﹤0.01% 549
2016
Q1 		$566K Buy
+11,715
New +$452K ﹤0.01% 576

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Jennison Associates's AMED Position: Q1 2022 in Review

Jennison Associates sold out of Amedisys (AMED) in Q1 2022, closing a stake of 28,667 shares — an estimated $4.64M sold.

Jennison Associates first reported a position in AMED in Q1 2016 and held it in 19 quarters. The position peaked at $4.64M in Q4 2021. 328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • Jennison Associates reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • Jennison Associates sold 28,667 Amedisys shares in Q1 2022, an estimated $4.64M.
  • Jennison Associates first reported a position in Amedisys in Q1 2016 and held it in 19 quarters.
  • Jennison Associates's Amedisys position peaked at $4.64M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Jennison Associates's 13F filing for Q1 2022, filed 11 May 2022.